- Home
- ADIL vs NUWE Comparison
ADIL vs NUWE Comparison
Compare ADIL & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADIL
- NUWE
- Stock Information
- Founded
- ADIL 2010
- NUWE 1999
- Country
- ADIL United States
- NUWE United States
- Employees
- ADIL N/A
- NUWE N/A
- Industry
- ADIL Biotechnology: Pharmaceutical Preparations
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ADIL Health Care
- NUWE Health Care
- Exchange
- ADIL Nasdaq
- NUWE Nasdaq
- Market Cap
- ADIL 3.9M
- NUWE 3.9M
- IPO Year
- ADIL 2018
- NUWE N/A
- Fundamental
- Price
- ADIL $0.34
- NUWE $0.23
- Analyst Decision
- ADIL Strong Buy
- NUWE Strong Buy
- Analyst Count
- ADIL 1
- NUWE 1
- Target Price
- ADIL $8.00
- NUWE $17.00
- AVG Volume (30 Days)
- ADIL 22.2M
- NUWE 30.9M
- Earning Date
- ADIL 08-12-2025
- NUWE 08-12-2025
- Dividend Yield
- ADIL N/A
- NUWE N/A
- EPS Growth
- ADIL N/A
- NUWE N/A
- EPS
- ADIL N/A
- NUWE N/A
- Revenue
- ADIL N/A
- NUWE $8,787,000.00
- Revenue This Year
- ADIL N/A
- NUWE $6.53
- Revenue Next Year
- ADIL N/A
- NUWE $51.63
- P/E Ratio
- ADIL N/A
- NUWE N/A
- Revenue Growth
- ADIL N/A
- NUWE N/A
- 52 Week Low
- ADIL $0.22
- NUWE $0.21
- 52 Week High
- ADIL $3.00
- NUWE $6.61
- Technical
- Relative Strength Index (RSI)
- ADIL 50.21
- NUWE 26.12
- Support Level
- ADIL $0.22
- NUWE $0.21
- Resistance Level
- ADIL $0.27
- NUWE $0.32
- Average True Range (ATR)
- ADIL 0.08
- NUWE 0.07
- MACD
- ADIL -0.01
- NUWE 0.00
- Stochastic Oscillator
- ADIL 53.15
- NUWE 11.43
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.